Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus

Lichen planus is considered a chronic inflammatory disease which affects different sites, such as the skin, mucous membranes, hair, and nails. Based on the evidence, a complex cytokine network plays a crucial role in lichen planus pathogenesis. The study was aimed at assessing the serum IL-23 levels...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Mardani, Hossein Mofidi, Ladan Dastgheib, Sara Ranjbar, Nasrin Hamidizadeh
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/5578568
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567733987835904
author Maryam Mardani
Hossein Mofidi
Ladan Dastgheib
Sara Ranjbar
Nasrin Hamidizadeh
author_facet Maryam Mardani
Hossein Mofidi
Ladan Dastgheib
Sara Ranjbar
Nasrin Hamidizadeh
author_sort Maryam Mardani
collection DOAJ
description Lichen planus is considered a chronic inflammatory disease which affects different sites, such as the skin, mucous membranes, hair, and nails. Based on the evidence, a complex cytokine network plays a crucial role in lichen planus pathogenesis. The study was aimed at assessing the serum IL-23 levels in the patients with cutaneous and oral lichen planus compared to healthy controls. Method. The study included 30 cutaneous lichen planus patients, 20 oral lichen planus patients, and 33 control subjects. Five milliliters of peripheral blood was obtained from each patient, and the serum was separated. IL-23 levels were determined using the ELISA kit, and the data were analyzed using the Mann–Whitney test. Results. IL-23 levels in the patient serum with oral lichen planus (P value ≤ 0.001) were significantly higher than in controls. Furthermore, there were significant differences in IL-23 serum levels in the patients with cutaneous lichen planus compared to the healthy controls (P value ≤ 0.001). Moreover, IL-23 serum levels were statistically different between patients with cutaneous lichen planus and patients with oral lichen planus (P value ≤ 0.001). Based on the mean concentration of interleukin-23, IL-23 levels were higher in the patients with oral lichen planus than in the patients with cutaneous lichen planus. Conclusions. Elevated serum IL-23 levels in the patients with oral lichen planus may indicate that IL-23 plays a crucial role in the pathogenesis of oral lichen planus. However, more research is needed with a larger sample size.
format Article
id doaj-art-772da7fc5c084b098685cb4001e9d9d7
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-772da7fc5c084b098685cb4001e9d9d72025-02-03T01:00:47ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/55785685578568Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen PlanusMaryam Mardani0Hossein Mofidi1Ladan Dastgheib2Sara Ranjbar3Nasrin Hamidizadeh4Oral and Dental Disease Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IranOral and Dental Disease Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IranMolecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, IranMolecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, IranMolecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, IranLichen planus is considered a chronic inflammatory disease which affects different sites, such as the skin, mucous membranes, hair, and nails. Based on the evidence, a complex cytokine network plays a crucial role in lichen planus pathogenesis. The study was aimed at assessing the serum IL-23 levels in the patients with cutaneous and oral lichen planus compared to healthy controls. Method. The study included 30 cutaneous lichen planus patients, 20 oral lichen planus patients, and 33 control subjects. Five milliliters of peripheral blood was obtained from each patient, and the serum was separated. IL-23 levels were determined using the ELISA kit, and the data were analyzed using the Mann–Whitney test. Results. IL-23 levels in the patient serum with oral lichen planus (P value ≤ 0.001) were significantly higher than in controls. Furthermore, there were significant differences in IL-23 serum levels in the patients with cutaneous lichen planus compared to the healthy controls (P value ≤ 0.001). Moreover, IL-23 serum levels were statistically different between patients with cutaneous lichen planus and patients with oral lichen planus (P value ≤ 0.001). Based on the mean concentration of interleukin-23, IL-23 levels were higher in the patients with oral lichen planus than in the patients with cutaneous lichen planus. Conclusions. Elevated serum IL-23 levels in the patients with oral lichen planus may indicate that IL-23 plays a crucial role in the pathogenesis of oral lichen planus. However, more research is needed with a larger sample size.http://dx.doi.org/10.1155/2021/5578568
spellingShingle Maryam Mardani
Hossein Mofidi
Ladan Dastgheib
Sara Ranjbar
Nasrin Hamidizadeh
Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
Mediators of Inflammation
title Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
title_full Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
title_fullStr Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
title_full_unstemmed Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
title_short Elevated Serum Interleukin-23 Levels in Patients with Oral and Cutaneous Lichen Planus
title_sort elevated serum interleukin 23 levels in patients with oral and cutaneous lichen planus
url http://dx.doi.org/10.1155/2021/5578568
work_keys_str_mv AT maryammardani elevatedseruminterleukin23levelsinpatientswithoralandcutaneouslichenplanus
AT hosseinmofidi elevatedseruminterleukin23levelsinpatientswithoralandcutaneouslichenplanus
AT ladandastgheib elevatedseruminterleukin23levelsinpatientswithoralandcutaneouslichenplanus
AT sararanjbar elevatedseruminterleukin23levelsinpatientswithoralandcutaneouslichenplanus
AT nasrinhamidizadeh elevatedseruminterleukin23levelsinpatientswithoralandcutaneouslichenplanus